Tigenix N.V.
Records under this name other than the patents Tigenix N.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 8 of 8 · Back to Tigenix N.V.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,253,632 | Biomaterial for Suturing Formerly held Term ended Term ended Feb 14, 2025 · Medium confidence | Term ended | Term ended Feb 14, 2025 | Medium confidence |
| US 7,842,502 | Use of CXCL6 chemokine for inducing precursor cells into chondrocytes Lapsed on the fee record Ended Nov 30, 2022 · From the USPTO record | Lapsed on the fee record | Ended Nov 30, 2022 | From the USPTO record |
| US 7,863,045 | Isolation of skeletal precursor cells Term ended Term ended Mar 18, 2021 · From the USPTO record | Term ended | Term ended Mar 18, 2021 | From the USPTO record |
| US 7,485,310 | Use of CXCL6 chemokine in the prevention or repair of cartilage defects Lapsed on the fee record Ended Feb 3, 2021 · From the USPTO record | Lapsed on the fee record | Ended Feb 3, 2021 | From the USPTO record |
| US 7,482,114 | In vivo assay and molecular markers for testing the phenotypic stability of cell populations, and selected cell populations for autologous transplantation Lapsed on the fee record Ended Jan 27, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jan 27, 2021 | From the USPTO record |
| US 7,479,367 | In vivo assay and molecular markers for testing the phenotypic stability of cell populations and selected cell populations for autologous transplantation Lapsed on the fee record Ended Jan 20, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jan 20, 2021 | From the USPTO record |
| US 9,089,598 | Method of treating connective tissue defect using chondrocytes selected for phenotypic stability Lapsed on the fee record Ended Jul 28, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jul 28, 2019 | From the USPTO record |
| US 8,740,811 | Biopsy device Formerly held Lapsed on the fee record Ended Jun 3, 2018 · From the USPTO record | Lapsed on the fee record | Ended Jun 3, 2018 | From the USPTO record |